Peripheral blood gene expression in postinfective fatigue syndrome following from three different triggering infections

Journal of Infectious Diseases

Volumn 204, Issue 10, 2011, Pages 1632-1640

  Galbraith, Sally ^a   Cameron, Barbara ^b   Li, Hui ^b   Lau, Diana ^c   Vollmer Conna, Ute ^b   Lloyd, Andrew R ^b  

^a Faculty of Science   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Children's Cancer Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; BCL 6 COREPRESSOR PROTEIN; BREAST CANCER METASTASIS SUPPRESSOR 1 PROTEIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARRIER PROTEINS AND BINDING PROTEINS; CHEMOKINE RECEPTOR CXCR4; DEFENSIN; EARLY GROWTH RESPONSE FACTOR 1; ENDOSULFINE ALPHA; LACTOFERRIN; PRKAR1A PROTEIN; PROTEIN DCTN1; PROTEIN SH2D1B; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ARF1 GENE; ARTICLE; BCOR GENE; BLOOD; BRMS1 GENE; CEACAM GENE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CXCR4 GENE; DCTN1 GENE; DISEASE DURATION; EGR1 GENE; ENSA GENE; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; LONGITUDINAL STUDY; LTF GENE; MALE; MICROARRAY ANALYSIS; ONSET AGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; POSTINFECTIVE FATIGUE SYNDROME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PRKAR1A GENE; Q FEVER; QUANTITATIVE ANALYSIS; ROSS RIVER ALPHA VIRUS; SH2D1B GENE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; ALPHAVIRUS INFECTIONS; CASE-CONTROL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; FATIGUE SYNDROME, CHRONIC; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; Q FEVER; ROSS RIVER VIRUS; YOUNG ADULT;

EID: 80054757042     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir612     Document Type: Article

References (50)

1. Candy B, Chalder T, Cleare AJ, et al. Predictors of fatigue following the onset of infectious mononucleosis. Psychol Med 2003; 33:847-55. (Pubitemid 36874664)
2. Cameron B, Bharadwaj M, Burrows J, et al. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load. J Infect Dis 2006; 193:664-71. (Pubitemid 43271499)
3. White PD. What causes prolonged fatigue after infectious mononucleosis: and does it tell us anything about chronic fatigue syndrome? J Infect Dis 2007; 196:4-5. (Pubitemid 46982729)
4. Petersen I, Thomas JM, Hamilton WT,White PD. Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort. QJM 2006; 99:49-55. (Pubitemid 43124971)
5. Afari N, Buchwald D. Chronic fatigue syndrome: A review. Am J Psychiatry 2003; 160:221-36. (Pubitemid 41110447)
6. Prins JB, van der Meer JWM, Bleijenberg G. Chronic fatigue syndrome. Lancet 2006; 367:346-55. (Pubitemid 43151468)
7. Lyall M, Peakman M, Wessely S. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res 2003; 55:79-90. (Pubitemid 37098388)
8. Cameron B, Hirschberg DL, Rosenberg-Hassan Y, Ablashi D, Lloyd AR. Serum cytokine levels in postinfective fatigue syndrome. Clin Infect Dis 2010; 50:278-9.
9. Vernon SD, Unger ER, Dimulescu IM, Rajeevan M, Reeves WC. Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers 2002; 18:193-9. (Pubitemid 36308196)
10. Powell R, Ren J, Lewith G, Barclay W, Holgate S, Almond J. Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients. Clin Exp Allergy 2003; 33:1450-6. (Pubitemid 37289944)
11. Grans H, Nilsson P, Evengard B. Gene expression profiling in the chronic fatigue syndrome. J Intern Med 2005; 258:388-90. (Pubitemid 41368691)
12. Kerr JR, Petty R, Burke B, et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis 2008; 197:1171-84. (Pubitemid 351590053)
13. Zhang L, Gough J, Christmas D, et al. Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol 2010; 63:156-64.
14. Byrnes A, Jacks A, Dahlman-Wright K, et al. Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: no evidence of a biomarker. PLoS One 2009; 4: e5805.
15. Hickie I, Lloyd A, Hadzi-Pavlovic D, Parker G, Bird K, Wakefield D. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med 1995; 25:925-35.
16. Wilson A, Hickie I, Hadzi-Pavlovic D, et al. What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry 2001; 35:520-7. (Pubitemid 32798770)
17. Vollmer-Conna U, Aslakson E, White PD. An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. Pharmacogenomics 2006; 7:355-64.
18. Fang H, Xie Q, Boneva R, Fostel J, Perkins R, Tong W. Gene expression profile exploration of a large dataset on chronic fatigue syndrome. Pharmacogenomics 2006; 7:429-40.
19. Aslakson E, Vollmer-Conna U, White PD. The validity of an empirical delineation of heterogeneity in chronic unexplained fatigue. Pharmacogenomics 2006; 7:365-73.
20. Carmel L, Efroni S, White PD, Aslakson E, Vollmer-Conna U, Rajeevan MS. Gene expression profile of empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 2006; 7:375-86.
21. Vernon SD, Reeves WC. The challenge of integrating disparate highcontent data: epidemiological, clinical and laboratory data collected during an in-hospital study of chronic fatigue syndrome. Pharmacogenomics 2006; 7:345-54.
22. Whistler T, Taylor R, Craddock RC, Broderick G, Klimas N, Unger ER. Gene expression correlates of unexplained fatigue. Pharmacogenomics 2006; 7:395-405.
23. Broderick G, Craddock RC, Whistler T, Taylor R, Klimas N, Unger ER. Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics 2006; 7:407-19.
24. Kerr JR, Burke B, Petty R, et al. Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: A detailed analysis of gene networks and clinical phenotypes. J Clin Pathol 2008; 61:730-9. (Pubitemid 351859965)
25. Kerr JR. Gene profiling of patients with chronic fatigue syndrome/ myalgic encephalomyelitis. Curr Rheumatol Rep 2008; 10:482-91.
26. Fostel J, Boneva R, Lloyd A. Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis. Pharmacogenomics 2006; 7:441-54.
27. Cannon TD, Keller MC. Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol 2006; 2:267-90. (Pubitemid 43799806)
28. Gow JW, Hagan S, Herzyk P, Cannon C, Behan PO, Chaudhuri A. A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics 2009; 2:38.
29. Cameron B, Galbraith S, Zhang Y, et al. Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis. J Infect Dis 2007; 196:56-66. (Pubitemid 46982738)
30. Robertson P, Beynon S, Whybin R, et al. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. J Med Virol 2003; 70:617-23. (Pubitemid 36734728)
31. Hickie I, Davenport T, Hadzi-Pavlovic D, et al. Development of a simple screening tool for common mental disorders in general practice. Med J Aust 2001; 175:S10-7. (Pubitemid 32700544)
32. Hadzi-Pavlovic D, Hickie I, Wilson A, Davenport T, Lloyd A, Wakefield D. Screening for prolonged fatigue syndromes: statistical and longitudinal validation of the SOFA scale. Soc Psychiatry Psychiatr Epidemiol 2000; 35:471-9.
33. Koschera A, Hickie I, Hadzi-Pavlovic D, Wilson A, Lloyd A. Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample. Aust N Z J Psychiatry 1999; 33:545-52. (Pubitemid 29386877)
34. Panelli M, Wang E, Phan G, et al. Gene expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration. Genome Biol 2002; 3:1-17.
35. Smyth G. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:article 3.
36. Hojsgaard S, Jun Y, Halekoh U. The R package geepack for generalized estimating equations. J Stat Softw 2005; 15:1-11.
37. Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006; 333:575-8. (Pubitemid 44433631)
38. Gow J, Hagan S, Herzyk P, Cannon C, Behan P, Chaudhuri A. A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics 2009; 2:38.
39. Kerr JR, Christian P, Hodgetts A, et al. Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments. J Clin Pathol 2007; 60: 113-6.
40. Ramilo O, Allman W, Chung W, et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007; 109:2066-77. (Pubitemid 46348207)
41. Zilliox MJ, Moss WJ, Griffin DE. Gene expression changes in peripheral blood mononuclear cells during measles virus infection. Clin Vaccine Immunol 2007; 14:918-23.
42. Merrow M, Spoelstra K, Roenneberg T. The circadian cycle: daily rhythms from behaviour to genes. EMBO Rep 2005; 6:930-5. (Pubitemid 41521947)
43. Riches P, Gooding R, Millar BC, Rowbottom AW. Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. J Immunol Methods 1992; 153: 125-31.
44. MAQC Consortium. The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006; 24:1151-61.
45. Whitney A, Diehn M, Popper SJ, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 2003; 100:1896-901. (Pubitemid 36254545)
46. Cho HJ, Skowera A, Cleare A, Wessely S. Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology. Curr Opin Psychiatry 2006; 19:67-73. (Pubitemid 44406148)
47. Hue S, Gray ER, Gall A, et al. Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010; 7:111.
48. Whistler T, Fletcher M, Lonergan W, et al. Impaired immune function in Gulf War illness. BMC Med Genomics 2009; 2:12.
49. Vernon S, Whistler T, Cameron B, Hickie I, Reeves W, Lloyd A. Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infect Dis 2006; 6:15.
50. Kaushik N, Fear D, Richards SCM, et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 2005; 58:826-32. (Pubitemid 41113389)